SCFAs appear to have a complex and pleiotropic role in obesity; on one hand, SCFAs may enhance energy harvest and contribute to excess lipogenesis in the liver, but also concurrently reduce inflammation, sensitize tissues to insulin, contribute to satiety and improve gut barrier function (Nehra et al., 2016). The gene discussed is INS; the disease is obesity disorder.